Eric T. Wong, Roy Tishler, Loretta Barron and Julian K. Wu Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas Cancer 101
Article first published online: 25 MAY 2004 | DOI: 10.1002/cncr.20339
The authors report their experience with an immunochemotherapy regimen, consisting of rituximab and temozolomide, that exhibited efficacy against recurrent PCNSL and against systemic non-Hodgkin lymphoma that had metastasized to the CNS. This immunochemotherapy combination may offer superior efficacy compared with either agent alone.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.